Global study finds no link between mRNA COVID-19 vaccines and Guillain-Barré syndrome risk

Global study finds no link between mRNA COVID-19 vaccines and Guillain-Barré syndrome risk

Publication date: Jun 06, 2025

“More information: Sharifa Nasreen et al, Risk of Guillain-Barr syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study, Vaccine (2025). This large-scale study underscores the importance of vaccination as a tool for public health, not only in preventing severe disease but in reducing rare complications like GBS. Dr. “Our findings highlight the importance of continuous monitoring and real-world data to guide public health decisions. Editors have highlighted the following attributes while ensuring the content’s credibility:A medical assistant prepares a dose of a COVID-19 vaccine to be administered to a patient. Steve Black, GVDN Co-Director, stated, “GVDN has long been committed to rigorous and transparent vaccine safety research. “”Understanding the relative risks of vaccination and infection is critical. The size and diversity of this study population, attained through multinational collaboration, is a testament to this.

Concepts Keywords
Denmark Cov
Finland Covid
Professor Dr
Vaccine Gbs
Gvdn
Infection
Monitoring
Public
Risk
Risks
Safety
Sars
Vaccination
Vaccine
Vaccines

Semantics

Type Source Name
disease MESH complications
disease IDO role
disease IDO infection
disease MESH influenza
disease MESH infections
disease MESH paralysis
pathway REACTOME SARS-CoV-2 Infection
disease MESH syndrome
disease IDO process
disease MESH SARS-CoV-2 infection

(Visited 1 times, 1 visits today)